NCT03611881View on ClinicalTrials.gov

Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS)

PHASE4CompletedINTERVENTIONAL
Enrollment

642

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Smoking, Tobacco
Interventions
BEHAVIORAL

Counseling

4 or 8 weeks of behavioral counseling support to promote smoking cessation.

DRUG

Nicotine patch

2 or 8 weeks of nicotine patch given in a tapering dose of 21 mg, 14 mg, 7 mg.

BEHAVIORAL

Community Resource

Counselor-facilitated referral to a community-based program to address social needs.

Trial Locations (6)

02114

Massachusetts General Hospital, Boston

02115

Brigham & Women's Hospital, Boston

02130

Brigham & Women's Faulkner Hospital, Boston

02462

Newton-Wellesley Hospital, Newton

02557

Martha's Vineyard Hospital, Oak Bluffs

01970

Salem Hospital, Salem

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT03611881 - Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS) | Biotech Hunter | Biotech Hunter